McKesson Corp (MCK)

NYSE · Health Care

1,011.61
-3.89 (-0.38%)
Updated Oct 22, 8:00 PM ET
AI Rating
Strong Buy
Overall Score
84
Trend
100
Momentum
78
Risk
65

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 8, 2025 260 sessions Oct 20, 2026

AI Analysis

McKesson Corp is trading at $1,015.50, down 1.42% on the session. The 50 day average sits at $902.25 and the 200 day at $855.96, which puts the stock in a uptrend. RSI is at 79.1, which reads as overbought, and MACD is bullish crossover. Volume is above average.

The nearest support is around $876.48 with resistance near $1,030.18, so that band frames the current range. Average daily movement is roughly $23.05, or about 2.3% of the share price, which is what any stop placement has to allow for. The overall health score of 84 out of 100 combines a trend score of 100, momentum of 78 and a risk score of 65.

Technical indicators

RSI (14)
79.1
overbought
MACD
34.106
bullish crossover
SMA 20
927.37
SMA 50
902.25
SMA 200
855.96
uptrend
ATR (14)
23.05
avg daily range
Support
876.48
Resistance
1,030.18
Volume vs 20d
1.12x
above average
Volatility
25.3%
annualised
1 month
+16.21%
3 months
+26.54%

About McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.